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Abstract 
The mechanism by which HSV exits the nucleus remains a matter of 
controversy. The generally accepted route proposes that capsids exit via 
primary envelopment at the inner nuclear membrane and subsequent fusion 
of this primary particle with the outer nuclear membrane to gain capsid entry 
to the cytoplasm. However recent observations indicate that HSV, and BHV, 
may induce gross morphological alterations of nuclear pores resulting in the 
loss of normal pores and the appearance of dilated gaps in the nuclear 
membrane of up to several 100 nms.  On this basis it was proposed that a 
main route of capsid exit from the nucleus is directly through these altered 
pores. Here we examine the biochemical composition of some of the major 
nuclear pore components in uninfected and HSV infected cells. We show that 
total levels of major nucleoporins and their sedimentation patterns in density 
gradients remain largely unchanged up to 18 hours after HSV infection. Some 
alteration in modification of one nucleoporin, Nup358/RanBP2 was observed 
during enrichment with anti-nucleoporin antibody and probing for o-
glycosylation. In addition we examine functional gating within the nucleus in 
live cells, using microinjection of labeled dextran beads and a recombinant 
virus expressing GFP-VP16 to track the progress of infection. The nuclear 
permeability barrier for molecules bigger than 70 kDa remained intact 
throughout infection.  Thus in a functional assay in live cells, we find no 
evidence for gross perturbation to the gating of nuclear pores, although this 
might not exclude a small population of modified pores.   
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Herpes simplex virus (HSV), like all herpesviruses, replicates and 
packages its genome into newly formed capsids inside the nucleus of infected 
cells. The nucleus is bounded by a nuclear envelope, a double lipid bilayer 
composed of the outer and inner nuclear membrane (ONM and INM 
respectively), which is underpinned on the nucleoplasmic side by the nuclear 
lamina, a dense meshwork of intermediate filaments formed from interlaced 
dimers of the lamins A/C and B.  Transport of molecules between the nucleus 
and cytoplasm normally takes place via nuclear pores embedded within and 
connecting the INM and ONM.  However progeny nucleocapsids, with a size 
of 100 nm are too large to pass through normal nuclear pores, which have a 
gating mechanism for  soluble proteins and assemblies through aqueous 
channels with a diameter of about 10 nm (reviewed in 1, 36, 48, 49).  It has 
been generally accepted therefore that a primary pathway of exit is via 
nucleocapsid attachment to the INM and subsequent budding into the lumenal 
space, thereby acquiring a primary lipid envelope (reviewed in 3, 9, 26, 44). 
However the mechanism by which HSV exits the nucleus remains a matter of 
controversy (27, 51).  An alternative pathway of capsid exit from the nucleus 
to the cytoplasm was proposed on the basis of high-resolution scanning and 
transmission electron microscopy (22, 52). These analyses indicated that 
infection resulted in gross enlargement of nuclear pores through which 
nuclear content including capsids was transported to the cytoplasm.  It was 
concluded that capsids use impaired nuclear pores as gateways to gain 
access to the cytoplasmic matrix.   While the weight of evidence strongly 
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favours nuclear exit by de-envelopment-re-envelopment model many issues 
remain to be resolved (27, 51). 
We have previously reported changes at the INM following HSV 
infection, exemplified by altered diffusional mobility of the lamin B receptor, 
dissociation of a population of lamin A/C  from the lamina (41) and 
hyperphosphorylation of a major nuclear membrane protein, emerin (29).    
Alterations in nuclear structure, the nuclear lamina and the INM were also 
reported in subsequent studies (2, 20, 33, 38, 42, 43) and have also been 
observed during CMV replication (30).  These alterations are likely to underpin 
major conformational changes in the nuclear envelope associated with access 
of the emerging capsid to the inner nuclear membrane and the relevant virus-
host interactions, in particular involving the essential proteins UL34 and UL31 
(12, 16, 17, 39, 40, 42). 
In this work, expanding on comparative analysis of nuclear 
components, we examine some of the major nuclear pore constituents in 
infected versus uninfected cells, and undertake a functional analysis of 
nuclear gating in live infected cells.   We found no major perturbations in the 
total levels of major nucleoporins (Nups) after infection or gross effects on 
sedimentation profiles in density gradients. Although other subtle changes 
may occur, we found no evidence for impairment or alteration in gating 
function of nuclear pores as evidences by exclusion of different sized dextrans 
beads in live infected cells.  Although qualifications may always be necessary,   
and local loss of nuclear pores could occur without overall affect on gating 
function, these results indicate that there is no discernible alteration in pore 
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function that would be expected from broad dismantling and loss of pores 
from the membrane.     
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Tissue Culture. 
Vero and Hep2 cells were maintained in Dulbecco's modified Eagle 
medium (DMEM) supplemented 100 units/ml penicillin, and 100 µg/ml 
streptomycin, with 10 % newborn calf serum (NBCS) at 37 ˚C in a 5 % CO2 
environment.  Infections were routinely performed in 35-mm dishes (2 x 105 
cells/well) at a multiplicity of infection (MOI) of 10 pfu/cell in DMEM with 2% 
NBCS. After adsorption of virus for 1 h at 37 ˚C and 5 % CO2 the medium was 
replaced with DMEM containing 10% NBCS and cells processed at the times 
indicated.  
 
Immunolocalisation.  
For immunolocalisation studies cells were plated and infected on 16 
mm borosilicate glass cover slips (BDH) placed in 35 mm cell culture dishes 
(Falcon).  Cells were fixed in an ice-cold mixture of equal volumes of ethanol 
and acetone for 15 min, rinsed, and permeabilised in PBS containing 50 mM 
NH4Cl, 0.5% Triton X-100 and 0.1% SDS 10 min.   The coverslips were 
further blocked in PBS containing 10% goat serum for 20 min and incubated 
for 20 min with anti-nucleoporin antibody mAb414 (Covance) diluted 1:2000 
and anti-VP22 antibody diluted 1:400 in blocking buffer. After washing in PBS, 
bound antibodies were detected using fluorescent-labelled secondary 
antibody (Molecular Probes). Cover slips were mounted in Mowiol (Sigma).  
Images were routinely acquired using a Zeiss LSM 410 confocal microscope 
with a Plan-Apochromat x63 oil immersion objective lens, NA 1.4 and zoom 
factors ranging from 1 to 8 of the LSM 410 acquisition software. 
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Monitoring the permeability of the nuclear envelope during infection 
was performed as described for previous studies on NPC gating during the 
cell cycle (21). Vero cells were plated in 35 mm plastic dishes which contained 
a gridded, glass insert, enabling the localisation and recovery of individual 
cells. Cells were infected with HSV-1 strain V41 expressing GFP-VP16 (19) at 
a MOI of 5 as described above. Prior to injection, the TRITC-labelled dextran 
beads (Molecular probes), with molecular weights of 10 or 70 kDa,  were 
diluted to 1 mg/ml in injection buffer (100 mM glutamate, 10 mM Hepes 
pH7.6) and centrifuged at 10,000g for 30 min (21).  Using a semi-automatic 
microinjector 5170 (Eppendorf) fitted to a Zeiss Axiovert 200 microscope, the 
beads were injected into the cytoplasm of individual uninfected cells or cells 
6h after infection with HSV-1 [v41].  For monitoring the progress of infection 
and imaging, the dishes were then transferred to a heated stage of the 
inverted LSM410 confocal microscope and monitored at different times 
thereafter. The intracellular localization of the TRITC-labelled dextran beads 
and GFP-VP16 expression in individual cells could then be recorded as 
described above. 
 
Sample preparation and Western Blotting. 
Mock-infected or HSV-1 infected cells (plated in 60 mm dishes) were 
washed in ice-cold PBS, then harvested in 1 ml ice-cold PBS buffer containing 
2 mM EDTA, 1 mM Na3VO4, 1 mM PMSF, 1 mM DTT, complete protease 
inhibitor mix (Roche Diagnostics) and pelleted at 2000 rpm for 5 min at 4 °C. 
The cell pellets were subsequently lysed in 200 µl RIPA buffer (50 mM Tris-
HCl pH 8.0, 150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 2 mM 
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EDTA, 1 mM Na3VO4, 1 mM PMSF, 1 mM DTT, 10 nM okadaic acid and 
complete protease inhibitor mix. Homogenates were incubated on ice for 
5 min, then briefly sonicated and centrifuged at 10,000 rpm for 5 min at 4ºC. 
SDS-PAGE and Western blotting were performed according to standard 
methods. The samples were denatured in SDS sample buffer at 45ºC for 15 
min and generally separated on Tris-acetate gradient gels 4-8% 
polyacrylamide (Invitrogen). Following electrophoresis, proteins were 
transferred onto Immobilon-P membranes (Millipore Corp.), which were 
blocked by incubation in methanol according to the manufacturer's protocol 
and then dried for 15 min at room temperature prior to incubation with primary 
antibody in PBST (PBS with 0.1% Tween20) with 0.5% BSA. For 
immunodetection, the membranes were incubated over-night with the 
following primary antibodies in PBST with 0.5% BSA diluted as follows: 
mAb414, 1:5000; anti-O-GlcNAc monoclonal antibody (Covance), 1:5000; and 
anti-VP5 antibody (Virusys), 1:2000. After washing, the membranes in PBST 
were incubated with horseradish peroxidase-conjugated anti-mouse or anti-
rabbit IgG secondary antibodies (Bio-Rad), and proteins were detected by 
ECL West Pico reagent (Pierce).   
 
Immunoprecipitation. 
Clarified cell homogenates prepared as above were diluted in ice-cold 
RIPA buffer supplemented with 0.5 µl antibody mAb414 or 20 µl wheat germ 
agglutinin (WGA)-sepharose (Vector Shield) and incubated over night at 4°C. 
The samples containing mAb414 or control samples were supplemented with 
20 µl protein-G sepharose and further incubated for 2h at 4°C with gentle 
rotation. Protein complexes were isolated by centrifugation 2000 rpm for 5 
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min, washed three times in RIPA buffer and analysed by SDS-PAGE and 
Western blotting.  
 
Nuclear envelope sucrose gradient fractionation  
Mock-infected and infected (MOI 10) Vero cells were harvested at 16 
hpi washed and centrifuged at 2000 rpm for 5 min. The cells were then 
suspended in 1 ml ice-cold hypotonic buffer (50 mM Hepes pH8, 5 mM MgCl2, 
2 mM DTT, 0.025% NP-40 and complete protease inhibitor mix), incubated for 
15 min on ice and then homogenized by 30 strokes in a glass Dounce 
homogeniser.  Isolation of nuclear envelopes was performed according to the 
method of Blobel (13) with modifications as described (24). After preparation 
the samples were further treated with DNaseI for 1h at +4º C and 
subsequently centrifuged at 10,000 g for 20 min.  The pellet containing 
nuclear envelopes was resuspended in 700 µl gradient buffer (50 mM Hepes 
pH8, 20% sucrose, 150 mM NaCl, 2 mM MgCl2, 0.1 mM EGTA) and 
transferred to centrifugation tubes preloaded with equal volumes of gradient 
buffer containing 70%, 50% and 30% sucrose. Gradients were subject to 
ultracentrifugation at 100,000g for 8 h in a Beckman AH650 rotor. After 
centrifugation, the gradients were fractionated from top to bottom and aliquots 
of single fractions were analysed by Western blotting with the appropriate anti-
nucleoporin antibodies. 
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Examination of nucleoporins in virus infected cells 
 
While recent work from several laboratories has begun to address 
alteration to the nuclear membrane and lamina during infection, there has 
been no work exploring biochemical composition and gating at the nuclear 
pore during infection.  To begin addressing these issues, we wished to 
examine whether HSV infection induced any gross compositional changes to 
some of the major constituents of nuclear pore complexes (NPCs).   The NPC 
is a dynamic, multiprotein complex comprised of different FG-repeat 
containing nucleoporins together with additional components assembled into a 
very large complex. The NPC spans, and is anchored to, the nuclear 
membrane and attaches to cytosolically disposed filaments and a 
nucleoplasmic basket (8, 10, 11, 15, 23, 35, 47, 53). Many of the core 
nucleoporins are composed of FG-repeats, clusters of hydrophobic 
phenylalanine-glycine amino acid repeats, which are thought to form a 
permeability barrier and enable selective gating though the nuclear pore (11, 
34, 46, 50). The FG-repeat containing nucleoporins may also function as 
adaptor proteins for different specific transport pathways. While the NPC has 
been regarded as a static channel through which dynamic transport of cargos 
takes place, more recent evidence indicates the pore complex is itself a 
dynamic complex whose composition may be regulated. 
 To begin to probe for alterations in the major NPC constituents, we 
made use of a well-characterised nucleoporin-specific antibody mAb414 (5) 
together with additional component specific antibodies. The mAb414 antibody 
specifically recognises a subset of the more prominent FG-repeat containing 
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nucleoporins, including Nup358, localised on the cytoplasmic face, Nup153 
and Nup214 on the nucleoplasmic face and Nup62 (p62) which is present in 
the central channel of the NPC.  We also examined NPC composition using 
antibodies to the membrane spanning proteins pom121 and gp210 and a 
separate specific antibody to Nup 62.  
In the first series of experiments, we analysed the progressive effect of 
HSV infection on NPCs by immunofluorescence and Western blotting. Cells 
infected by HSV-1 were fixed at different times after infection and probed with 
mAb414 (Fig. 1). In uninfected cells we observed a dense nuclear pattern 
enriched around and lining the whole nuclear envelope (Fig 1, M). During 
infection, while the nucleus alters in shape and size, we observed a modest 
but distinct change in the pattern of staining of mAb414, with what appeared 
to be micro-clusters around the nuclear rim between 12 and 18 h.    In many 
cells we also observed a minor but distinct speckled cytoplasmic staining, 
though this was also occasionally observed in uninfected cells. Curiously we 
also observed a slight increase in intensity of overall staining under identical 
conditions, though this was lost at very late times (Fig 1, 12, 18 , 24 hpi).  We 
do not know the reason for this effect which could be due to epitope 
unmasking or to a real increase, but we note we did not observe any increase 
in the abundance of the nucleoporins by Western blotting (see below). Taking 
into account the increase of the nuclear volume and the deformation of the 
nuclear envelope induced by HSV infection, localisation of Nups by mAb414 
showed no gross morphological change or loss at least until very late times 
during infection.  
In parallel we examined the profile of the major Nups by Western 
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blotting with mAb414. We wished additionally to examine the O-glycosylation 
status of Nups since this is one of the major post-translational modifications of 
the Nups (6, 14, 28, 32, 45) and indeed antibody to N-acetylglucosamine (O-
GlcNAc) detects certain Nups that are not as readily detected by mAb414.  
The results demonstrate that during infection, monitored in this case by the 
progressive accumulation in VP5, no major difference in abundance of the 
major Nups was detected with mAb414 (Fig. 2a). Interestingly, using the anti-
O-GlcNAc antibody, an increase in modification could be detected from 12-18 
hpi.  Although the precise identify of all the proteins detected by this antibody 
are not known, many have been shown to be Nups (6, 14, 28, 45).  Given the 
stable levels of the Nups detected by mAb414, one explanation for this result 
could be increased modification by O-glycosylation, either generally or 
specifically of Nups.  Either way we certainly did not observe any obvious loss 
of these components.  
 
Analysis of isolated nuclear envelopes 
 
While total levels of NPC components appear constant during the main course 
of infection, the composition and integrity of the NPC was analysed in more 
detail by sucrose gradient centrifugation. Nuclear envelopes preparations 
were made from cells 16 h after infection or mock infection as described in 
materials and methods and loaded onto a 5-70% sucrose gradient. After 
ultracentrifugation the gradients were fractionated and analysed by Western 
blotting.  Nuclear envelope fractions were first analysed for the presence and 
distribution of nucleoporins with the mAb414 (Fig.3).  Nucleoporins Nup 358, 
214 and 153 co-sedimented in the gradient, with fractionations from 
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uninfected and from infected cells resulting in very similar distribution patterns 
(Fig.3a, b).  
Peak fractions from uninfected and infected cells were also analysed 
for the presence of other nuclear pore components, the membrane spanning 
nucleoporins pom121, gp210 and the central channel protein Nup62 (Fig. 3c) . 
No significant changes in the abundance or distribution of these components 
were observed (Fig. 3c and data not shown).  
Immunoprecipitation of nucleoporins 
 
Continuing to probe for potential differences in levels or association of 
nucleoporins during HSV infection, we analysed the Nups by the 
immunoprecipitation and subsequent Western blotting of the associated 
proteins. These analyses were performed using either the antibody mAb414 
or wheat germ agglutinin-coupled agarose (WGA). WGA selectively enriches 
for proteins modified by N-acetylglucosamine (O-GlcNAc) modification and is 
frequently used as a probe for the O-GlcNAc-modified Nups as described 
above. 
The results show parallel samples from mock infected (Fig. 4, M) and 
infected cells (Fig.4, HSV) as follows; total extracts (lanes 1,2),  enriched 
mAb414-precipitated samples (lanes, 3,4) and the WGA-enriched samples,  
detected firstly by Western blotting with mAb414 (panel a). In the total 
samples, Nups 358, 214, 153 and p62 were seen with little alteration as 
observed earlier (c.f., lanes 1,2).   In mAb414 immunoprecipitated, the ratios 
of the Nups changed somewhat with for example Nup153, and p62 appearing 
relatively enriched (cf., lanes 1 and 3). Additional bands in the precipitate 
represented antibody species in the primary immunoprecipitates.   The 
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alteration in detection in the precipitate versus the total sample likely 
represents differences in ratios of these components in different 
subcomplexes present in the extract and precipitated by the antibody. 
Nevertheless for those Nups detected, again there was no major change in 
uninfected versus infected extract (c.f., lanes 3,4).   We noted one possible 
exception to this in that Nup358, while present in the total infected cell extract, 
was selectively under-represented in the infected cells immunoprecipitates 
compared to the other Nups (c.f., Nup358 lanes 3,4 versus e.g., Nup 214 or 
153, lanes 3,4).  This relative reduction in Nup358 immunoprecipitates was 
also observed when enriching components using WGA, then probing for Nups 
with mAb414 (c.f., lanes 5,6). In addition, we probed the same samples i.e. 
total extracts, mAb414 immunoprecipitates and WGA enriched fractions with 
antibody to O-GlcNAc (Fig. 5b).  In the total samples, not al bands will be 
detected with the same efficiency as when probing with mAb414. However the 
results indicate that while the total levels of Nup358 in uninfected and infected 
cells were similar (panel a, lanes 1,2),  the levels of O-GlcNAc Nup358 were 
reduced in infected cells (panel b, lanes 1,2).  This relative reduction was 
again observed in the WGA-enriched fraction, when probed with the O-
GlcNAc antibody (panel b, lanes 5,6).   One explanation consistent with these 
results is that while HSV does not induce major changes to these major pore 
constituents, nevertheless changes in the levels of O-glycosylated Nup358 
may occur, (panel b, 1,2)  and in the recruitment of a population of Nup358 
into mAb414 precipitable complexes (panel, a, lanes 3,4).  Overall these 
results indicate HSV infection does not result in major changes in the 
composition of these major components of NPCs nor their levels or 
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association. However specific modifications to selected proteins of the NPC, 
exemplified by underglycosylation of Nup358 may occur and this could have 
bearing on NPC function, gating or selectivity. 
 
Permeability barrier of the nuclear envelope during HSV-1 infection 
 
The transport of large proteins and assemblies between the cytoplasm and 
nucleoplasm is regulated by the gating properties of the NPCs which restricts 
molecules larger than 10 nm or 45 kDa from passive diffusion between the 
compartments.   The nucleo-cytoplasmic transport of molecules beyond the 
limit for passive diffusion therefore requires an active transport mechanism, 
dependent upon specific signals and adaptors and catalysed by specific 
import-export machinery.  Many previous studies on localisation of herpes 
virus components have included parallel examination of the steady state 
location of certain host cell nuclear components.  Profound reorganisation of 
the nucleus and of bulk nuclear components such as host cell chromatin have 
been noted in previous studies (4, 7, 18, 25, 37, 43). However while the 
appearance of nuclear proteins, such as inner nuclear membrane proteins, 
within cytoplasmic membranes has been observed, major dislocation of 
nuclear proteins to the cytoplasm has not been reported.  Nevertheless, given 
recent results from electron microscopy on major structural alteration to NPCs 
and the proposal for direct exit of capsids of 100 nm diameter through 
modified pores, we wished to examine functional gating of NPCs in live 
infected cells.     
One route to examine the permeability of NPCs in vivo is by micro-
injection of inert fluorescently-tagged dextran beads of defined size (21).  
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Beads of defined size are injected into the cytoplasm and if below the 
threshold for passive diffusion (e.g. 10 kDa) rapidly equilibrate in the nucleus 
and throughout the cell. Beads above the gating threshold (e.g. 70 kDa) 
remain excluded from the nucleoplasm. To establish the system we first 
analysed the distribution of TRICT-labelled 10 kDa and 70 kDa beads after 
microinjection into the cytoplasm of uninfected Vero cells.  Concentrations of 
beads and microinjection procedures were designed based on previous work 
(21)  and are detailed in materials and methods. After injection, cells were 
incubated and monitored for the distribution of the beads. Typical results 
showing the distribution of the different sized beads are shown on Fig.4a.  All 
cells injected with the 10 kDa dextran beads showed homogeneous 
distribution throughout the cell. In contrast the majority of the 70 kDa beads 
remained in the cytoplasm, though minor amounts were observed in the 
nucleus, and occasionally (< 5%) cells injected with the 70 kDa beads 
exhibited a diffuse distribution throughout the cell.  This latter feature may be 
due to inadvertent nuclear injection or pressure during injection, possibly 
division, but did not affect the main conclusions from the study (see below). 
To pursue the effects of infection on gating we used a HSV-1 strain [HSV-
V41] expressing GFP-VP16.  To obviate any potential effect of microinjection 
on infection itself, our approach was to first infect cells, then to 6 hours after 
infection to randomly inject the infected cells with fluorescent TRITC-labeled 
10 or 70 kDa beads. The localization of the injected fluorescent beads was 
then analysed in parallel to the expression and localization of GFP-VP16 at 
different time points. At least 50 microinjected cells were examined for each 
bead size. As expected the 10 kDa beads distributed equally between the 
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cytosol and nucleoplasm and this distribution did not change during the time 
course between 8 to 24 hpi, showing no restriction e.g. from diffusion within 
the nuclear viral replication centres (data not shown). The distribution of the 
70 kDa sized beads in typical fields is shown in Fig. 4b,c.  In Fig 4b,   each of 
the cells in the central patch contains cytoplasmic-restricted 70 kDa beads 
(left panel), and each of these cells exhibits pronounced VP16 expression 
typified by VP16 recruitment into lobular nuclear replication compartments 
(right panel).  The distribution of the 70 kDa beads in these cells is 
indistinguishable from that seen in uninfected cells (Fig.4a, right panel). 
Additional fields of microinjected cells are shown in Fig.4 panel C, in this case 
showing the merged images of TRITC-70 kDa beads and VP16-GFP in the 
same fields.   Again in cells well in advanced stages with VP16 recruited into 
coalescing replication compartments and in cytoplasmic vesicular pattern as 
described previously (19), TRITC-labelled 70 kDa beads remained largely 
excluded from the nucleus. No general difference in this pattern was observed 
at any time point studied (at least up to 18 hpi), indicating that nuclear 
envelope appeared to be intact. We interpret these results to indicate that, at 
least at this level of resolution, the nuclear envelope permeability barrier 
remained predominantly intact for particles of 70 kDa (36 nm) or larger size 
throughout the time course of normal HSV infection.  
 
. 
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Herpesvirus nucleocapsids, of 100 nm diameter, are too large to pass through 
normal nuclear pores, which have aqueous channels incorporating a gating 
mechanism for selective transport of soluble proteins and nucleoprotein 
assemblies (reviewed in 48).  It has been generally accepted therefore that in 
the initiation of infection, HSV capsids do not enter the nucleus intact, but 
rather undergo some structural rearrangement which results in capsid 
breakdown and DNA (or nucleoprotein complex) entry to the nucleus. 
Similarly it is generally accepted that the primary pathway of nuclear exit is via 
capsid attachment to the INM and subsequent budding into the lumenal 
space, thereby acquiring a primary lipid envelope (reviewed in 3, 9, 26, 44). 
However the mechanism by which HSV exits the nucleus remains a matter of 
controversy (27, 51) and an alternative pathway of capsid exit from the 
nucleus to the cytoplasm has been proposed on the basis of high-resolution 
electron microscopy (22, 52). These analyses indicated that infection resulted 
in gross enlargement of nuclear pores to between 300 to 500 nm, and up to 
1000 nm, through which nuclear content including capsids were transported to 
the cytoplasm.   
Several reports have now documented significant changes to nuclear 
structure, specifically the nuclear membrane and underlying lamina following 
HSV infection (2, 38, 41-43).  A recent report also indicated that HSV-1 
infection induces the recruitment of certain kinases to the nuclear rim, 
resulting in phosphorylation of lamina components (33).  As an extension to 
these observations, it could be that significant modifications are made to 
nuclear pore structure and function, but currently there is little direct analysis. 
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The main aim of this work was to examine gating in live HSV infected cells, 
since it would be reasonably predicted that gross alteration of the sort 
described above, sufficient to allow transport of a macromolecular assembly 
such as capsids,  would have a significant  effect on nuclear transport and 
gating controls.   Cumulative observations on the selective accumulation of 
regulatory factors, DNA replication components etc within the nucleus,  would 
not of themselves provide evidence that gating remained intact since there is 
the possibility, if not the likelihood, of selective retention of nuclear 
components or assemblies.  We set out to perform an analysis that has not 
been previously reported upon, namely the examination of gating in live 
infected cells.  We used an approach similar to that employed in the 
examination of breakdown of the nuclear envelop in mitosis (21), 
microinjecting fluorescently tagged dextran beads of different sizes and 
identifying and monitoring infection using a GFP expressing virus.   We 
observed selective retention of the 70 kd beads in the cytoplasm, (as opposed 
to free diffusion of 10 kd beads), but could find no significant difference in the 
distribution of the 70 kd beads during infection when late replication 
compartments were formed, monitoring up to 18 h after infection.    
Several possibilities may be put forward in the attempt to reconcile 
these observations. For example it could be that within the profoundly 
rearranged nuclear pores, normal gating was either retained or indeed the 
altered pores impenetrable for normal soluble phase transport.   We view this 
as unlikely.  What might be more plausible is that the pore disruption that was 
reported is relatively rare and localized, and does not register as a change in 
the total diffusional capacity of the nucleus, such as our assay examines.  If 
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this were the case, it would require a spatially restricted mechanism to induce 
pore alteration, and likely mean that any exit through such altered pores was 
also spatially restricted.  
However while there was little evidence for alteration in functional 
gating there was evidence for modification of some sort to the pore. In their 
original work Leuzinger et al., (22) examined NPC using anti-Nup153 antibody 
and reported increasing presence of Nup 135 in the cytoplasm of infected 
cells, similar to that observed here using Mab414. Similar results were also 
recently reported by Nagel et al., (31)  who observed cytoplasmic presence, 
occasionally in foci, consistent with our observations. They also reported 
clustering of Nups and the appearance of large gaps in the otherwise 
continuous rim pattern of staining.  These gaps were not necessarily 
associate with the pore alteration as observed by electron microscopy,  and 
the authors also pointed out  that in the majority of cells with cytoplasmic 
capsids, the nuclear pore architecture as observed in their studies was 
unchanged (31).   Although we did not observe major disruption in 
biochemical sedimentation analysis, two modifications merit further comment.  
We reproducibly observed an increase in the profile of high molecular weight 
o-glycosylated proteins, amongst which Nups are known to be the major 
constituents. Although we do not know the identity of the major species 
involved, it could be that such modification plays a role in pore function in 
infection.   For example, considering the efficiency once in the cytoplasm with 
which an infecting capsid must dock at the pore, it remains unclear how 
capsids after egress do not reattach to pores, engendering a type of futile 
cycle.  The relative efficiency of docking of capsids to pores of infected cells 
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has not been examined, but it is possible that pore alterations which did not 
affect gating, could affect virus-pore interaction.    The other alteration which 
we observed was in reduced amounts of Nup358 in immunoprecipitated 
complexes with other Nups. While modest this was a reproducible finding with 
2-3 fold reductions not observed for other Nups.  Nup358 is also known as 
RanBP2 and is a Sumo-specific E3 ligase involved in proper targeting of other 
pore proteins such as RanGap1. Further investigation should help reveal 
specific alteration to Nup358/RanBP2 function and location, and the possible 
involvement in such modification to altered trafficking of proteins or complexes 
at the pore. 
In summary, functional analysis in living cells demonstrated no 
significant difference in partitioning or nuclear pore gating in HSV infected 
cells.   The results are consistent with the proposal that egress in infected 
cells is via an envelopment-deenvelopment route and that disrupted pores are 
not a major route of capsid exit to the cytoplasm.  
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Figure Legends 
Figure1 
Immunofluorescence of nuclear pore proteins at different time points after 
infection with HSV-1. Cells (Hep2 cells) were infected with HSV-1 at an moi of 
10, or mock infected, and washed fixed and stained with the nucleoporin 
specific antibody mAb414 at the times indicated. Higher magnifications of 
typical images of single cells are shown in row (b).  
 
Figure 2 
Analysis of major nucleoporins during HSV1 infection.  Cells were infected 
with HSV-1 at an moi of 10 and samples taken at different time points as 
indicated.   Aliquots of the extracts were denatured immediately in SDS 
sample buffer and  separated on 4-8% gradient SDS-PAGE gels,  transferred 
to PVDF membranes and stained with mAb414 to detect  nucleoporins 
Nup358, Nup214 and Nup153 proteins.  Parallel samples were probed with O-
GlcNAc specific antibody. In parallel samples were probed with antibody to 
the major capsid protein VP5 to monitor virus infection. Sizes of molecular 
weight marker proteins are show in kDa at the right. 
 
Figure 3 
Gradient fractionation of nucleoporins from isolated nuclear envelopes from 
(a) uninfected or (b) HSV-infected cells.  Cells (Hep2 cells) were infected at an 
moi of 10 and at 16 hpi nuclear envelope preparations were made as 
described in materials and methods.  The extracts were fractionated by 
sucrose density ultracentrifugation, fractions harvested from top to bottom and 
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aliquots analysed by Western blotting with mAb414. Fractions numbers are 
indicated at the top of the Western blots. In addition panel C shows the peak 
fraction 8 in each case,  probed separately with different antibodies for the 
presence of additional nucleoporins as indicated.  
 
Figure 4 
Immunoprecipitation of nucleoporins. The composition of the NPC was further  
compared between uninfected (M, column 1, 3 and 5) and HSV-1 infected 
cells (I, column 2, 4 and 6) by immunoprecipitation.  Cells (Hep2 cells) were 
infected as before and aliquots of total cell lysates used for the 
immunoprecipitation are in lanes1 and 2 (Input). Nucleoporins were affinity 
purified either by antibody mAb414 (lanes 3,4) or by WGA-sepharose in 
(lanes 5,6).  Aliquots of the enriched fractions were analysed by Western blot.  
Nucleoporins were detected in  by antibody Ab414 (a) or by an antibody to O-
GlcNAc modified proteins (b). The sizes of the molecular weight marker and 
the position of the corresponding nucleoporins indicated at the right and left 
side, respectively. 
 
Figure 5 
Analysis of the permeability of the nuclear envelope during HSV1 infection. 
Panel a. Uninfected Vero cells were microinjected microinjected with 10 kDa 
or 70 kDa TRITC-labelled dextran beads as indicated.   After injection, live 
cells were analysed by confocal microscopy for the distribution of the 
fluorescent beads. Typical results from numerous fields are illustrated. Panel 
b. Cell were infected with HSV-1 [V41], expressing GFP labelled VP16 and 6 
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hours later microinjected with the 70 kDa TRITC-labelled dextran beads.  
Monolayers were incubated at 370Cand monitored for the progression of 
infection and localisation of VP15-GFP,  and in parallel in the same cells for 
the localisation of the  70 kDa TRITC-labelled dextran beads at different time 
points after infection. A typical field the separate distribution of VP16-GFP and 
TRITC dextran 16 hpi is shown. Panel C.  As for panel b, with two merged 
fields showing TRITC and VP16 in the same field.  These fields were taken 16 
hpi and are typical of many fields analysed.    
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